Health CanadaGeneral Alert
RITUXAN (rituximab) - Hepatitis B Virus (HBV) Recurrence in Patients: Updates on Screening and Management - For the Public
Published: July 29, 2013Recall ID: 49662Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
RITUXAN (rituximab) - Hepatitis B Virus (HBV) Recurrence in Patients: Updates on Screening and Management - For the Public
Recalling Firm: Marketed health products
Reason for Recall / Hazard
Product safety
Product Description & Identification
RITUXAN (rituximab) - Hepatitis B Virus (HBV) Recurrence in Patients: Updates on Screening and Management - For the Public
Additional Source Details
| Field | Value |
|---|---|
| N I D | 49662 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/rituxan-rituximab-hepatitis-b-virus-hbv-recurrence-patients-updates-screening-and |
| Issue | Product safety |
| Title | RITUXAN (rituximab) - Hepatitis B Virus (HBV) Recurrence in Patients: Updates on Screening and Management - For the Public |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2013-07-29 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - RITUXAN (rituximab) - Hepatitis B Virus (HBV) Recurrence in Patients: Updates on Screening and Management - For the Public Check if your household is affected: https://therecallfile.com/recalls/rituxan-rituximab-hepatitis-b-virus-hbv-recurrence-in-patients-updates/CANADA-49662
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordRITUXAN (rituximab) - Hepatitis B Virus (HBV) Recurrence in Patients: Updates on Screening and Management - For the Public